InsidersTradesSigma
Follow the Cannara Biotech Inc. stock price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are listed on CA CA, under the oversight of SEDI. Market capitalisation: €181.8m. The latest transaction was disclosed on 10 July 2026 (37 - Stock split or consolidation). Among the most active insiders: Landry, France. The full history is free.
Analysts rate Cannara Biotech Inc. Strong Buy (bullish), based on 4 analysts. Average price target: CA$3.19.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Cannara Biotech Inc. is a Canadian company focused on the production of cannabis-based products. It is listed on the Toronto Stock Exchange under the symbol XTSE.